Condition
Normal Tension Glaucoma
ClinicalTrials.gov condition label
Clinical trials
38 shownTranscorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle GlaucomaNCT06682962 · 2025-04-02
RECRUITINGDeep Sclerectomy Versus Trabeculectomy in Normal Tension GlaucomaNCT05371977 · 2022-05-31
RECRUITINGEndoscopic Cyclophotocoagulation in Normal Tension GlaucomaNCT04651530 · 2020-12-08
RECRUITINGInvestigation of Neurovascular Coupling in Glaucoma Patients and Healthy SubjectsNCT03870230 · 2017-12-01
RECRUITINGObstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing BlindnessNCT06023927 · 2025-09-02
NOT_YET_RECRUITINGEffect of Netarsudil vs Brimonidine in NTG Patients on LatanoprostNCT06449352 · 2024-06-13
COMPLETEDR&D of Non-invasive Innovative Intracranial Waves Monitoring System for Diagnostics and Treatment Monitoring of Patients with Normal Tension GlaucomaNCT06443411 · 2024-04-22
UNKNOWNDirect Selective Laser Trabeculoplasty in Ethnic Chinese PopulationNCT05902871 · 2024-03-11
ACTIVE_NOT_RECRUITINGEVALUATION of CATS TONOMETER PRISM in LASIK SUBJECTSNCT06266351 · 2024-02-12
COMPLETEDStudy in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag IsopropylNCT05279716 · 2022-02-15
UNKNOWNWater Drinking Test Study and Disc Hemorrhages in Normal Tension GlaucomaNCT05075369 · 2021-10-01
UNKNOWNIntraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension GlaucomaNCT04981886 · 2021-08-01
UNKNOWNComputer-aided Diagnosis of Ocular Diseases Based on Corneal BiomechanicsNCT04475900 · 2020-07-09
COMPLETEDReproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI SystemNCT04014933 · 2019-07-01
COMPLETEDMeasurement of the Effect of Gingko Biloba Extract on Ocular and Nailfold Blood-flow in NTGNCT03761992 · 2018-11-19
UNKNOWNPeripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography StudyNCT03323164 · 2017-07-10
COMPLETEDEvaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension GlaucomaNCT03106532 · 2017-03-06
COMPLETEDAdvanced Glycation End Products as a Biomarker for Accelerated AgeingNCT02863224 · 2016-08-01
COMPLETEDEfficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)NCT02863705 · 2016-07-05
COMPLETEDPressure Difference Between Brain and Eye: a Possible Cause to Normal Tension Glaucoma.NCT02776449 · 2016-02-01
COMPLETEDAssessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor ImagingNCT01864317 · 2015-11-01
TERMINATEDInvestigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension GlaucomaNCT01995136 · 2013-09-01
COMPLETEDOcular Blood Flow in Glaucoma Patients - the Leuven Eye StudyNCT01840202 · 2013-02-01
COMPLETEDStudy on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal VeinsNCT01794442 · 2013-01-01
UNKNOWNStudy on Ocular Blood Flow and the Orbital Cerebrospinal Fluid Pressure in GlaucomaNCT01802463 · 2013-01-01
COMPLETEDCorrelation of Orbital Cerebrospinal Fluid Pressure and Retinal Venous Outflow in Primary Open-angle GlaucomaNCT01795014 · 2013-01-01
UNKNOWNRelationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAGNCT01769521 · 2012-10-01
COMPLETEDIntraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension GlaucomaNCT01175902 · 2011-03-01
COMPLETEDDifferences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-GlaucomaNCT01488032 · 2011-03-01
COMPLETEDIOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology ClinicNCT01254149 · 2011-01-17
COMPLETEDEfficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension GlaucomaNCT01446497 · 2010-10-01
UNKNOWNAutonomic Nervous System Activity and Normal Tension GlaucomaNCT01192061 · 2010-02-01
COMPLETEDSerum Bilirubin Levels in Normal-tension GlaucomaNCT03387306 · 2010-01-01
COMPLETEDProtective Effect of Phenytoin on GlaucomaNCT00739154 · 2008-11-01
UNKNOWNA New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood PressureNCT00706056 · 2008-09-01
COMPLETEDSystemic Glutathione Level in Normal Tension GlaucomaNCT00570362 · 2008-03-01
COMPLETEDMagnetic Resonance Imaging of Patients With Normal Tension GlaucomaNCT00175786 · 2005-07-01
COMPLETEDMacular Retinoschisis and Detachment Associated With Glaucomatous Optic NeuropathyNCT01862627 · 2004-12-01
COMPLETEDCommon interventions
7-Tesla MRIDEVICE1Applanation TonometryOTHER1Bimatoprost OphthalmicDRUG1bimatoprost ophthalmic solution 0.01%DRUG1BrimonidineDRUG1Brimonidine TartrateDRUG1brimonidine tartrate/timolol malate Ophthalmic SolutionDRUG1Brimonidine/Timolol mixed combinationDRUG1Clinical observation, diagnostic testingOTHER1Corneal biomechanics (Corvis ST, Oculus, Wetzlar, Germany)DIAGNOSTIC_TEST1Corneal topography and tomography (Pentacam, Oculus, Wetzlar, Germany)DIAGNOSTIC_TEST1Deep SclerectomyPROCEDURE1Direct Selective Laser TrabeculoplastyPROCEDURE1dorzolamide/timololDRUG1Dynamic Vessel Analyzer (DVA)DEVICE1External Automatic Glaucoma LaserDEVICE1Eybelis ophthalmic solution 0.002%DRUG1Fourier Domain Doppler Optical Coherence Tomography (FDOCT)DEVICE1Gingko BalobaDIETARY_SUPPLEMENT1Heidelberg Retina TomographyOTHER1Humphrey PerimetryOTHER1LASER SPECKLE FLOWGRAPHYDIAGNOSTIC_TEST1Laser Speckle Flowgraphy (LSFG)DEVICE1latanoprostDRUG1Monitoring of cerebral hemodynamicsOTHER1
Leading sponsors
Universitaire Ziekenhuizen KU Leuven4Helsinki University Central Hospital2Medical University of Vienna2Technische Universität Dresden2The Catholic University of Korea2Alcon Research1Allergan1BelkinVision1Intuor Technologies, Inc.1Kyorin University1Lithuanian University of Health Sciences1Military Institute od Medicine National Research Institute1Northwell Health1Okuvision GmbH1pH Pharma1
Trial status mix
COMPLETED22
UNKNOWN9
RECRUITING4
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
TERMINATED1
Phase mix
NA9
PHASE47
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.